HSV GENE THERAPY

Viral gene therapy is a therapeutic approach that utilizes viruses to deliver genetic material into cells, aiming to treat or prevent diseases at the genetic level. Viruses are engineered to remove toxic genes, while retaining their ability to infect cells. Aeno-associated virus (AAV) vectors are the leading platform for viral gene therapy, but 83% of genes are too large to be contained within them. We're focused on utilizing HSV's large cargo space to delivery big genes to treat rare genetic diseases.